A study of 162,500 patients with uterine cancer found that survival rates varied significantly by race and geographic location, with Black patients experiencing the worst survival outcomes in ...

Endometrial cancer (EC) is the most common gynecologic cancer in developed countries, and incidence is rising as a result of increased obesity and ageing of the population. 1 The relative 5-year ...

In this video, Ursula A. Matulonis, MD, discusses preliminary efficacy and safety results for puxitatug samrotecan in patients with recurrent endometrial cancer. Findings from a phase 1/2a study ...

Treatment paradigms for endometrial cancer are rapidly evolving. New minimally invasive surgical techniques have helped to reduce the morbidity of women with early-stage tumors undergoing ...

GSK’s Jemperli has claimed an edge over its main rival in the endometrial cancer therapy market after showing improved overall survival in a broad patient population in the RUBY trial.

GSK and Merck & Co have both reported new clinical data with the PD-1 checkpoint inhibitors, seeking an edge in the first-line treatment of advanced endometrial cancer. Results of GSK’s RUBY ...

kidney and uterine cancers. Scientists from the National Cancer Institute looked at data that included more than 2 million cancers diagnosed in people 15 to 49 years old between 2010 and 2019.

Projections suggest breast and ovarian cancer cases will rise, while cervical and uterine cancer cases may decline by 2050. As National Women’s Health Week approaches, new global data ...

The studies span breast cancer and other solid tumors (glioblastoma, endometrial cancer, lung cancer, gastric cancer), as well as multiple blood cancers (multiple myeloma, large B-cell lymphoma ...

The former Real Housewives of Beverly Hills star celebrated one year of being cancer-free in January. The mother of two was diagnosed with endometrial cancer back in 2013 and underwent a radical ...